1. Home
  2. HBIO vs NYC Comparison

HBIO vs NYC Comparison

Compare HBIO & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.30

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Logo American Strategic Investment Co.

NYC

American Strategic Investment Co.

HOLD

Current Price

$8.26

Market Cap

24.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
NYC
Founded
1901
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.9M
24.8M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
HBIO
NYC
Price
$6.30
$8.26
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
26.1K
27.2K
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
85.28
EPS
N/A
N/A
Revenue
$116,176,000.00
N/A
Revenue This Year
$4.77
$56.73
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$7.03
52 Week High
$7.50
$16.30

Technical Indicators

Market Signals
Indicator
HBIO
NYC
Relative Strength Index (RSI) 53.07 43.75
Support Level $6.05 $7.84
Resistance Level $7.00 $8.63
Average True Range (ATR) 0.44 0.84
MACD 0.05 -0.15
Stochastic Oscillator 67.58 1.34

Price Performance

Historical Comparison
HBIO
NYC

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: